Article
Open Access
Time Optimal Control Studies on COVID-19 Incorporating Adverse Events of the Antiviral Drugs
-
Bishal Chhetri
Published/Copyright:
December 13, 2021
Received: 2021-05-28
Accepted: 2021-11-19
Published Online: 2021-12-13
© 2021 Bishal Chhetri et al., published by De Gruyter
Articles in the same Issue
- Special Issue: Computational and Mathematical Bioscience for COVID-19
- Modeling COVID-19 in Cape Verde Islands - An application of SIR model
- Social heterogeneity and the COVID-19 lockdown in a multi-group SEIR model
- Stability analysis of a fractional ordered COVID-19 model
- Detections and SIR simulations of the COVID-19 pandemic waves in Ukraine
- Modelling of a two prey and one predator system with switching effect
- Special Issue: Drug Design and Discovery for COVID-19
- Antiviral Resistance against Viral Mutation: Praxis and Policy for SARS-CoV-2
- Special Issue: COVID-19 and Dynamics of Infectious Diseases
- Low temperatures or high isolation delay increases the average COVID-19 infections in India : A Mathematical modeling approach
- Optimal Control of a Dengue-Dengvaxia Model: Comparison Between Vaccination and Vector Control
- Time Optimal Control Studies on COVID-19 Incorporating Adverse Events of the Antiviral Drugs
- Are the upper bounds for new SARS-CoV-2 infections in Germany useful?
- Effect of Vaccination to COVID-19 Disease Progression and Herd Immunity
- Research Articles
- A Study of Within-Host Dynamics of Dengue Infection incorporating both Humoral and Cellular Response with a Time Delay for Production of Antibodies
- An Optimal Control Study with Quantity of Additional food as Control in Prey-Predator Systems involving Inhibitory Effect
- Impact of fear in a prey-predator system with herd behaviour
- Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection
- Regulation of early growth response-1 (Egr-1) gene expression by Stat1-independent type I interferon signaling and respiratory viruses
Keywords for this article
COVID-19;
First Line Drugs;
Second Line Drugs;
Adverse Events;
Time Optimal Control Problem;
Bang-Bang Control
Creative Commons
BY 4.0
Articles in the same Issue
- Special Issue: Computational and Mathematical Bioscience for COVID-19
- Modeling COVID-19 in Cape Verde Islands - An application of SIR model
- Social heterogeneity and the COVID-19 lockdown in a multi-group SEIR model
- Stability analysis of a fractional ordered COVID-19 model
- Detections and SIR simulations of the COVID-19 pandemic waves in Ukraine
- Modelling of a two prey and one predator system with switching effect
- Special Issue: Drug Design and Discovery for COVID-19
- Antiviral Resistance against Viral Mutation: Praxis and Policy for SARS-CoV-2
- Special Issue: COVID-19 and Dynamics of Infectious Diseases
- Low temperatures or high isolation delay increases the average COVID-19 infections in India : A Mathematical modeling approach
- Optimal Control of a Dengue-Dengvaxia Model: Comparison Between Vaccination and Vector Control
- Time Optimal Control Studies on COVID-19 Incorporating Adverse Events of the Antiviral Drugs
- Are the upper bounds for new SARS-CoV-2 infections in Germany useful?
- Effect of Vaccination to COVID-19 Disease Progression and Herd Immunity
- Research Articles
- A Study of Within-Host Dynamics of Dengue Infection incorporating both Humoral and Cellular Response with a Time Delay for Production of Antibodies
- An Optimal Control Study with Quantity of Additional food as Control in Prey-Predator Systems involving Inhibitory Effect
- Impact of fear in a prey-predator system with herd behaviour
- Profiling transcription factor sub-networks in type I interferon signaling and in response to SARS-CoV-2 infection
- Regulation of early growth response-1 (Egr-1) gene expression by Stat1-independent type I interferon signaling and respiratory viruses